-
Device Promises Faster Schistosomiasis Diagnosis
A piece of kit that quickly multiplies the DNA of parasitic worms could detect infections by schistosome species more than six times faster than the most accurate existing method.
- Categories
- Health Care
-
Gates-Backed NYC Startup Plumbs Soil Bacteria for Tuberculosis Therapy
Countless therapeutics – and certainly our earliest ones – were discovered from natural sources. Lodo Therapeutics, a new small molecule drug discovery startup based in New York City, is basing its platform on this premise: It will develop medicines that can be produced by uncultured soil bacteria and the human microbiome, chasing global health indications like tuberculosis.
- Categories
- Health Care
-
Weekly Roundup: Starting SDGs, Africa’s IT Meritocracy, Safaricom’s Setback
The United Nations’ Sustainable Development Goals (SDGs) officially took effect on Jan. 1, with the stated goals of freeing “the human race from the tyranny of poverty and want and to heal and secure our planet” over the next 15 years. Whew. Talk about a tall order.
- Categories
- Health Care, Technology
-
Brazil Cuts Vaccine Doses as Health System Under Pressure
Brazil has cut the number of doses for vaccinations given by the public health service to counter human papillomavirus (HPV) and pneumonia, as Latin America's largest economy looks to reduce health costs in the midst of a deep recession.
- Categories
- Health Care
- Region
- Latin America
- Tags
- vaccines
-
Cholera Vaccine Supply Set to Double, Easing Global Shortage
Globally, OCV production is low, with demands currently exceeding supply. Sudan and Haiti last year made requests to WHO for supplies of vaccines to conduct pre-emptive vaccination campaigns that could not be filled because of the global shortage.
- Categories
- Health Care
- Tags
- vaccines
-
10 Global Health Trends from 2015 and What They Mean for the New Year
It's not too early in 2016 to see a few emerging themes: a transition toward local ownership of health priorities, financing and implementation; a growing need to understand and target specific segments of populations; and a shift in focus to several emerging areas of opportunity which are new to the global health agenda.
- Categories
- Health Care
-
Prominent Healthcare Companies Partner With USAID
The U.S. Agency for International Development (USAID) announced two new partnerships today to add resources and cutting-edge technologies to fight drug-resistant tuberculosis (TB). Janssen, the pharmaceutical arm of Johnson & Johnson, announced a $15-20 million pledge as part of a new partnership with USAID to combat Multidrug-Resistant Tuberculosis (MDR-TB). USAID will also partner with Cepheid, a maker of molecular systems and tests, to speed diagnosis of MDR-TB through increased access to rapid, accurate diagnostic tools.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Gavi, India PM discuss strategic vaccine partnership
Gavi, a global vaccine alliance, proposes to have a new strategic partnership with India for 2016-2021, which will see further fund support of up to $500 million to accelerate the introduction of modern vaccines for all children in the country.
- Categories
- Health Care
- Region
- South Asia